West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 65,300 | 72,600 | 86,600 | 71,200 | 67,100 |
| Depreciation Amortization | 73,200 | 68,100 | 60,600 | 56,600 | 52,700 |
| Income taxes - deferred | -1,800 | -4,800 | 7,300 | -6,400 | 4,900 |
| Accounts receivable | 9,400 | -6,000 | 1,900 | -20,500 | 2,800 |
| Accounts payable and accrued liabilities | -300 | -700 | -3,300 | 16,000 | 15,800 |
| Other Working Capital | -12,500 | -15,600 | -30,100 | -15,000 | -5,200 |
| Other Operating Activity | 5,000 | 24,100 | 12,000 | 27,300 | 1,300 |
| Operating Cash Flow | $138,300 | $137,700 | $135,000 | $129,200 | $139,400 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -71,100 | -104,900 | -138,600 | -129,400 | -90,300 |
| Net Acquisitions | -3,700 | -16,900 | N/A | N/A | N/A |
| Purchase Of Investment | -7,200 | -2,700 | N/A | -22,700 | N/A |
| Sale Of Investment | N/A | 5,300 | 16,800 | N/A | N/A |
| Purchase Sale Intangibles | -2,700 | -2,900 | -500 | -4,700 | N/A |
| Other Investing Activity | 8,000 | -2,700 | 2,100 | -3,800 | 400 |
| Investing Cash Flow | $-74,000 | $-121,900 | $-119,700 | $-155,900 | $-89,900 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -1,100 | -4,300 | 3,100 | 300 | -2,000 |
| Debt Issued | 0 | N/A | N/A | 156,300 | 100,100 |
| Debt Repayment | 26,600 | 16,400 | 9,500 | -19,100 | -157,700 |
| Common Stock Issued | 3,700 | 5,000 | 6,200 | 4,400 | 5,700 |
| Common Stock Repurchased | -2,100 | -1,300 | -5,200 | -43,000 | -1,300 |
| Dividend Paid | -21,700 | -20,100 | -18,600 | -17,500 | -15,900 |
| Other Financing Activity | -39,400 | -18,300 | -24,400 | 3,200 | 10,900 |
| Financing Cash Flow | $-34,000 | $-22,600 | $-29,400 | $84,600 | $-60,200 |
| Exchange Rate Effect | -3,200 | 2,700 | -7,100 | 3,400 | 4,600 |
| Beginning Cash Position | 83,100 | 87,200 | 108,400 | 47,100 | 48,800 |
| End Cash Position | 110,200 | 83,100 | 87,200 | 108,400 | 47,100 |
| Net Cash Flow | $27,100 | $-4,100 | $-21,200 | $61,300 | $-1,700 |
| Free Cash Flow | |||||
| Operating Cash Flow | 138,300 | 137,700 | 135,000 | 129,200 | 139,400 |
| Capital Expenditure | -71,100 | -104,900 | -138,600 | -129,400 | -90,300 |
| Free Cash Flow | 67,200 | 32,800 | -3,600 | -200 | 49,100 |